Roper Technologies
ROP
358.57
-3.71
-1.02%
Roper Technologies
US · ROP
#609 by market cap
Listed 1970
358.57
-3.71
-1.02%
Live - 5344 symbols - heartbeat 75s ago
· 2026-10-08 04:00
Pre-market
358.57
0.00%
After-hours
358.57
0.00%
Overnight
358.64
+0.02%
- Market cap
- 35.46B
- P/E (TTM)i
- 14.94
- P/Bi
- 1.90
- EPSi
- 14.20
- Div yieldi
- 0.97%
- 52W posi
- 26%
Reader sentiment
Are you bullish or bearish on ROP?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.52, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +12.26% YoY
Margins
- Gross margin
- 69.24%
- Operating margin
- 28.29%
- Net margin
- 19.44%
Key ratios & quality
- Enterprise valuei
- 44.51B
- Altman Z-Scorei
- 2.52
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 5.19B | 4.73B | 4.02B | 4.83B | 5.37B | 6.18B | 7.04B | 7.90B |
| Gross profit | 3.28B | 3.14B | 2.83B | 3.41B | 3.75B | 4.31B | 4.88B | 5.47B |
| Selling & admin expenses | 1.88B | 1.81B | 1.75B | 2.07B | 2.23B | 2.56B | 2.88B | 3.24B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 1.40B | 1.33B | 1.08B | 1.34B | 1.52B | 1.75B | 2.00B | 2.24B |
| Pretax profit | 1.20B | 2.06B | 861.30M | 1.03B | 1.28B | 1.74B | 1.97B | 1.94B |
| Tax | 254.00M | 417.40M | 187.50M | 226.60M | 296.40M | 374.70M | 417.90M | 399.80M |
| Net profit | 944.40M | 1.77B | 949.70M | 1.15B | 4.54B | 1.38B | 1.55B | 1.54B |
| Basic EPS | 9 | 17 | 9 | 11 | 43 | 13 | 14 | 14 |
| Diluted EPS | 9.05 | 16.82 | 8.98 | 10.82 | 42.55 | 12.89 | 14.35 | 14.20 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.88B | 1.94B | 2.02B | 2.06B | 2.10B | 2.11B |
| Gross profit | 1.29B | 1.35B | 1.40B | 1.43B | 1.45B | 1.47B |
| Selling & admin expenses | 767.90M | 797.10M | 830.00M | 841.60M | 884.20M | 885.50M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 525.80M | 548.30M | 573.00M | 588.30M | 569.60M | 584.70M |
| Pretax profit | 418.00M | 485.30M | 498.20M | 534.60M | 635.00M | 1.31B |
| Tax | 86.90M | 107.00M | 99.70M | 106.20M | 126.10M | 139.50M |
| Net profit | 331.10M | 378.30M | 398.50M | 428.40M | 508.90M | 1.17B |
| Basic EPS | 3 | 4 | 4 | 4 | 5 | 12 |
| Diluted EPS | 3.06 | 3.49 | 3.68 | 3.97 | 4.87 | 11.62 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.61B | 2.00B | 1.75B | 2.42B | 1.93B | 1.48B | 1.54B | 1.93B |
| Cash & ST investments | 364.40M | 709.70M | 308.30M | 351.50M | 792.80M | 214.30M | 188.20M | 297.40M |
| Inventory | 190.80M | 198.40M | 165.10M | 69.20M | 111.30M | 118.60M | 120.80M | 141.70M |
| Total assets | 15.25B | 18.11B | 24.02B | 23.71B | 26.98B | 28.17B | 31.33B | 34.58B |
| Total current liabilities | 1.45B | 2.40B | 2.44B | 3.12B | 2.89B | 2.96B | 3.83B | 3.73B |
| Short-term debt | 1.50M | 659.00M | 556.20M | 840.70M | 745.60M | 542.80M | 1.09B | 753.50M |
| Long-term debt | 4.94B | 4.67B | 9.06B | 7.12B | 5.96B | 5.83B | 6.58B | 8.60B |
| Total liabilities | 7,511,000,000.00 | 8,617,000,000.00 | 13,545,000,000.00 | 12,150,100,000.00 | 10,943,000,000.00 | 10,722,700,000.00 | 12,467,100,000.00 | 14,695,500,000.00 |
| Total equity | 7.74B | 9.49B | 10.48B | 11.56B | 16.04B | 17.44B | 18.87B | 19.88B |
| Retained earnings | 6.25B | 7.82B | 8.55B | 9.46B | 13.73B | 14.82B | 16.03B | 17.21B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.70B | 1.65B | 1.80B | 1.93B | 1.91B | 1.92B |
| Cash & ST investments | 372.80M | 242.40M | 320.00M | 297.40M | 382.90M | 364.90M |
| Inventory | 125.50M | 132.20M | 140.80M | 141.70M | 144.50M | 145.40M |
| Total assets | 31.42B | 33.22B | 34.58B | 34.58B | 34.55B | 35.17B |
| Total current liabilities | 3.69B | 3.56B | 3.13B | 3.73B | 3.58B | 3.47B |
| Short-term debt | 999.40M | 999.80M | 300.00M | 753.50M | 715.60M | 718.30M |
| Long-term debt | 6.46B | 7.86B | 9.15B | 8.60B | 9.75B | 10.60B |
| Total liabilities | 12,195,200,000.00 | 13,586,500,000.00 | 14,591,600,000.00 | 14,695,500,000.00 | 15,732,800,000.00 | 16,469,200,000.00 |
| Total equity | 19.22B | 19.63B | 19.99B | 19.88B | 18.82B | 18.70B |
| Retained earnings | 16.28B | 16.57B | 16.88B | 17.21B | 17.62B | 18.70B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1.43B | 1.46B | 1.53B | 2.01B | 734.60M | 2.04B | 2.39B | 2.54B |
| Depreciation & amortization | 367.00M | 408.80M | 491.60M | 615.90M | 650.10M | 755.20M | 812.80M | 898.20M |
| Free cash flow | 1.37B | 1.41B | 1.48B | 1.95B | 664.30M | 1.93B | 2.28B | 2.44B |
| Dividends paid | -170.10M | -191.70M | -214.10M | -236.40M | -262.30M | -290.20M | -321.90M | -355.00M |
| Stock buybacks / issuance | 5.40M | 6.80M | 10.50M | 15.10M | 14.30M | 15.50M | 18.50M | -477.60M |
| Ending cash balance | 364.40M | 709.70M | 308.30M | 351.50M | 792.80M | 214.30M | 188.20M | 297.40M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 528.70M | 404.10M | 869.50M | 738.00M | 592.10M | 469.50M |
| Depreciation & amortization | 213.10M | 223.70M | 231.10M | 230.30M | 230.40M | 230.60M |
| Free cash flow | 506.80M | 373.20M | 841.90M | 713.70M | 562.40M | 443.00M |
| Dividends paid | -88.60M | -88.60M | -88.80M | -89.00M | -97.40M | -94.00M |
| Stock buybacks / issuance | 7.20M | 5.30M | 4.90M | -495.00M | -1.49B | -1.22B |
| Ending cash balance | 372.80M | 242.40M | 320.00M | 297.40M | 382.90M | 364.90M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 12.94 | 20.52 | 9.51 | 10.46 | 32.93 | 8.27 | 8.53 | 7.93 |
| ROA %i | 6.39 | 10.60 | 4.51 | 4.83 | 17.93 | 5.02 | 5.21 | 4.66 |
| ROIC %i | 8.81 | 13.93 | 6.42 | 6.73 | 22.20 | 6.50 | 6.96 | 6.44 |
| 5-year avg ROE %i | 13.69 | 14.91 | 14.04 | 13.76 | 17.27 | 16.34 | 13.94 | 13.62 |
| EBIT margin %i | 26.59 | 44.98 | 25.84 | 26.05 | 27.45 | 30.88 | 31.63 | 28.61 |
| FCF / sales %i | 26.42 | 26.07 | 26.71 | 33.74 | 12.37 | 31.19 | 32.42 | 30.82 |
| Current ratioi | 1.11 | 0.83 | 0.72 | 0.78 | 0.67 | 0.50 | 0.40 | 0.52 |
| Quick ratioi | 0.87 | 0.71 | 0.47 | 0.36 | 0.58 | 0.40 | 0.32 | 0.42 |
| Debt / assetsi | 32.41 | 29.44 | 40.03 | 33.58 | 24.86 | 22.63 | 24.48 | 27.04 |
| LT debt / equityi | 63.84 | 49.23 | 86.47 | 61.59 | 37.18 | 33.42 | 34.87 | 43.24 |
| Interest coveragei | 7.58 | 12.94 | 6.52 | 6.43 | 7.66 | 11.58 | 8.59 | 6.96 |
| Revenue CAGR (3Y) %i | 13.16 | 7.65 | -4.43 | -2.35 | 4.35 | 15.38 | 13.35 | 13.73 |
| Net income CAGR (3Y) %i | 10.71 | 38.98 | -0.76 | 6.87 | 36.99 | 13.38 | 10.36 | -30.34 |
| FCF CAGR (3Y) %i | 15.50 | 15.10 | 8.06 | 12.52 | -22.16 | 9.13 | 5.32 | 54.20 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 8.09 | 8.15 | 8.16 | 7.93 | 9.01 | 13.07 |
| ROA %i | 4.88 | 4.88 | 4.75 | 4.66 | 5.20 | 7.32 |
| ROIC %i | 6.55 | 6.51 | 6.42 | 6.44 | 7.15 | 9.69 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 29.97 | 30.02 | 29.72 | 28.61 | 30.99 | 40.69 |
| FCF / sales %i | 31.44 | 30.57 | 31.16 | 30.82 | 30.70 | 30.93 |
| Current ratioi | 0.46 | 0.46 | 0.58 | 0.52 | 0.53 | 0.55 |
| Quick ratioi | 0.36 | 0.37 | 0.46 | 0.42 | 0.42 | 0.44 |
| Debt / assetsi | 23.73 | 26.67 | 27.34 | 27.04 | 30.29 | 32.19 |
| LT debt / equityi | 33.59 | 40.03 | 45.79 | 43.24 | 51.80 | 56.69 |
| Interest coveragei | 8.07 | 7.99 | 7.59 | 6.96 | 6.96 | 8.56 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Application Software is the largest reported line at 55.99% of revenue, across 3 reported segments.
- Technology Enabled Products follows at 23.58%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Application Software55.99%
Technology Enabled Products23.58%
Network Software20.43%
Quote time 2026-10-08 04:00:01 · For reference only, not investment advice and not tailored to your situation.